IndigoBridge Laboratories is a translational medicine biotechnologies company promising to uphold the three main pillars of this interdisciplinary branch of the biomedical field: Benchside, Bedside and Community; bridging the gap between the science and the clinic.

​

Translational research is the process of applying ideas, insights, and discoveries generated through basic scientific inquiry to the treatment or prevention of human disease and ageing. Given this definition, our mission at IndigoBridge is to commercialize effective and accurate high-throughput assays that impact prevention and to monitor treatment of the most prominent diseases affecting our health in today’s world, as well as those that serve as markers for ageing. 

​

​Research supports a wide range of therapeutic benefits from the cannabinoids in hemp. Our analyses aim to ensure that products are of the appropriate purity and potency to provide the desired health outcomes.